According to the Report, the Size of the Coagulation/Hemostasis analyzer market is expected to reach USD 4.84 billion by 2025, growing at a CAGR of 10.2% during the forecast period 2020 - 2025.
These analyzers are very much helpful in examining the hemostasis system in laboratories. Coagulometers are used in various methods such as to observe blood clots in the blood. Coagulation analyzers follow easy steps to measure blood platelet levels. The early diagnosis of the hemostasis system can prevent blood clots which might cause heart attacks. Most importantly coagulation analyzers can evaluate the thromboline and thromboplastine concentrations in very less time. Also, these analyzers are user-friendly as they can evaluate the required measurement in a few minutes and which helps to prevent bleeding to blood clots.
The major factor driving the demand of the market is the rising number of cardiovascular problems across the world. Changes in lifestyles and increasing obesity cases due to changes in food habits are also some common factors propelling the growth rate of the coagulation/hemostasis market. In addition, creating awareness over the availability of diagnostics procedures that can prevent heart attacks is enhancing the demand of this market. A growing number of people suffering from blood disorders is accelerating the growth rate of the market to the extent.
However, lack of standardization is slowly hindering the growth rate of the market. Automatic coagulation analyzers require huge amounts for installation and maintenance which is remained as a challenging factor for the market developers. Strict rules and regulations by government organizations in approving medical equipment are also impeding the growth rate of the coagulation/hemostasis analyzers market. The availability of alternative devices that are highly advanced at a lower price is quietly limiting the demand of the market. People in rural areas are less aware of these techniques due to lack of proper knowledge in the utilization of the analyzers and this is degrading the growth rate of the market.
Focus on the development of innovative techniques and the rise in the number of research centers in the biotechnology field is to create growth opportunities for the coagulation/hemostasis analyzers market. Increasing prevalence for automation equipment in laboratories is greatly influencing the demand of the market eventually. The growing geriatric population is also one of the factors gearing up the growth rate of the market. Constant economic growth in both developed and developing countries is lucratively surging the demand of the market. Increasing investments in healthcare by private and public organizations is also impacting the demand of the market towards positive.
Recent Developments:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 – 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 - 2025 |
|
Segments Covered |
By Tests, Products, End Users, Technology, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France). |
This research report on the Global Coagulation/Hemostasis Analyzer Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Coagulation/Hemostasis Analyzer Market - By Test
On the basis of test, prothrombin time testing has the largest market share in this segment and is also the fastest-growing due to increasing automation of this process in laboratories.
Coagulation/Hemostasis Analyzer Market - By Product
On the basis of product, Clinical laboratory analyzers have the largest market in this segment.
Coagulation/Hemostasis Analyzer Market - By End Users
On the basis of end-user, Clinical laboratories have the largest share in the segment.
Coagulation/Hemostasis Analyzer Market - By Technology
On the basis of technology, the Optical segment has the largest market share and is also the fastest-growing in this segment.
Regional Analysis
North America Coagulation/Hemostasis Analyzer Market is expected to hold the largest share and also is projected to dominate the global coagulation/hemostasis analyzer market contributing over 35.0% share in terms of revenue. The growth is due to frequent increase in lifestyle diseases such as obesity, diabetes and cardiovascular disorders, and growing repetition of blood disorders. US has the highest share in the hemostasis analyzer market and the quickest growing market in the region as there is a common repetition of cardio metabolic disorders like pulmonary embolism and deep vein thrombosis. Canada is next to the United States.
Europe Coagulation/Hemostasis Analyzer Market is expected to stand as the second largest market in the coagulation/hemostasis analyzer next to North America. The factors driving the market in Europe region increasing elder people population, growing occurrence rate of chronic blood diseases, poor lifestyle changes and rising blood relevant disorders. Germany is expected to have USD 132.7 million in this region and is projected to dominate the region in the next upcoming years.
Asia-Pacific Coagulation/Hemostasis Analyzer Market is projected to have quickest growth rate with highest CAGR in the coagulation/hemostasis analyzer market during the forecast period. As a result of advancements in healthcare infrastructure in countries like China, Japan and India, growing number of general surgeries and increasing number of research activities taking place is few countries of APAC region. China is predicted to showcase potentiality to grow with 12.7% in the forthcoming years.
Latin America Coagulation/Hemostasis Analyzer Market is still in the developing stages as increasing number of people who are suffering with chronic blood disorders, enlargement of hospitals and healthcare centers with in short span of time which is propelling the growth of the market in this region. Moreover, huge amount spent on research and development incorporated with increasing awareness in the advanced technologies foster the hemostasis analyzer market. Also, upgrade of high-sensitivity point of care coagulation testing, and augment in laboratory automation fuel the growth.
Middle East & Africa Coagulation/Hemostasis Analyzer Market is expected to witness profitable growth rate which is attributed due to sufficient hospitals, health centers and clinics backed by expert healthcare professional staff outfitted to provide protective and effective healthcare. Moreover, rising elder people population base, quick advancements in foreign investments, particularly in advancing nations of this region are likely to augment the hemostasis analyzer market growth. The growth in this reason is caused by potentiality of the devices and perfect results with in very less time.
Key Market Participants dominating the Global Coagulation/Hemostasis Analyzer Market Profiled in the Report are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan), Diagnostica Stago (France).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Test
5.1.1 ACT
5.1.2 aPTT
5.1.3 D Dimer testing
5.1.4 Platelet Function Test
5.1.5 Prothrombin Time Testing
5.1.6 Anti-Factor Xa Test
5.1.7 Heparin and Protamine Dose Response Test for ACT
5.1.8 Fibrinogen Testing
5.1.9 Other Coagulation Tests
5.1.10 Y-o-Y Growth Analysis, By Test
5.1.11 Market Attractiveness Analysis, By Test
5.1.12 Market Share Analysis, By Test
5.2 Product
5.2.1 PoC Testing Analyzers
5.2.2 Clinical Laboratory Analyzers
5.3 End Users
5.3.1 Clinical Laboratories
5.3.2 Point-Of-Care Testing
5.3.3 Other End Users
5.3.4 Y-o-Y Growth Analysis, By End Users
5.3.5 Market Attractiveness Analysis, By End Users
5.3.6 Market Share Analysis, By End Users
5.4 Technology
5.4.1 Electrochemical Technology
5.4.2 Optical Technology
5.4.3 Mechanical Technology
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technology
5.4.6 Market Attractiveness Analysis, By Technology
5.4.7 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Test
6.1.3.2 By Product
6.1.3.3 By End Users
6.1.3.4 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Test
6.1.4.2 By Product
6.1.4.3 By End Users
6.1.4.4 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Test
6.1.5.2 By Product
6.1.5.3 By End Users
6.1.5.4 By Technology
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Siemens AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Roche Diagnostics
8.4 Alere Inc.
8.5 Sysmex Corporation
8.6 Helena Laboratories
8.7 Instrumentation Laboratory
8.8 International Technidyne Corporation
8.9 Nihon Kohden Corporation
8.10 Diagnostica Stago
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
